06955 博安生物
按盤價 
9.700 +0.410 (+4.413%) | 日期 | 股東名稱 | 披露原因 | 買入／賣出涉及 的股份數目 |
每股平均價 | 持有權益的 股份數目 |
佔已發行 股本(%) |
| 07/08/2024 | 李莉 | 1213(L) | 47,638,668(L) | 8.89 | ||
| 07/08/2024 | Nelumbo Investments Limited | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | 山东绿叶制药有限公司 | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | Luye Pharma Group Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | Ginkgo (PTC) Limited | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | Luye Pharma Hong Kong Limited | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | Luye Pharma Holdings Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | AsiaPharm Investments Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | Shorea LBG | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | LuYe Pharmaceutical International Co., Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | 刘殿波 | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | 烟台绿叶医药控股（集团）有限公司 | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 07/08/2024 | Luye Life Sciences Group Ltd | 1213(L) 1213(S) | 360,596,456(L) 74,387,153(S) | 67.28 13.88 | ||
| 12/04/2024 | LuYe Pharmaceutical International Co., Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | Shorea LBG | 1701(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | LuYe Pharmaceutical Investment Co., Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | AsiaPharm Investments Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | Luye Pharma Holdings Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | Ginkgo (PTC) Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | Luye Pharma Hong Kong Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | 山东绿叶制药有限公司 | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | 烟台绿叶医药控股（集团）有限公司 | 1701(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | 刘殿波 | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | Luye Life Sciences Group Ltd | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | Luye Pharma Group Ltd. | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 12/04/2024 | Nelumbo Investments Limited | 1316(S) | +74,387,153(S) | 360,596,456(L) 74,387,153(S) | 70.81 14.61 | |
| 1 | ||||||
| 備註： | (L) - 長倉：包括 (1) 持有股份；(2) 透過持有、沽出或發行金融合約，有權或有責任購買相關股份。 |
| (S) - 短倉：包括 (1) 借入股份；(2) 透過持有、沽出或發行金融合約，有權或有責任沽出相關股份。 | |
| (P) - 可供借出的股份 | |
| 即時報價更新時間為 27/09/2024 17:59 | |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
